Gamunex-c 20 gram/200 ML vial 200ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG2LV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,087
Award facts
- Contract value 100% obligated
- $22,086.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,086.90 to AmerisourceBergen Drug Corp for the supply of Gamunex-C, a 20-gram immunoglobulin product in 200-milliliter vials. This competitively awarded, firm fixed-price contract carries an ultimate completion date of January 13, 2026, with performance to be executed at the contractor's Conshohocken, Pennsylvania facility. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime indefinite delivery vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates capability across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies. This delivery order for Gamunex-C—an immunoglobulin replacement therapy—reflects the company's ongoing role in fulfilling specialized pharmaceutical requirements for Defense Health Agency customers and other federal healthcare systems. No set-aside designation was applied to this award.
Quick answers
Who was awarded contract SPE2DR26FG2LV?
SPE2DR26FG2LV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FG2LV worth?
The government has obligated $22,087 on SPE2DR26FG2LV.
Is contract SPE2DR26FG2LV an order under another contract?
Yes. SPE2DR26FG2LV is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG2LV competed?
The extent of competition for SPE2DR26FG2LV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award